Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta


Wranke A., Heidrich B., Ernst S., Serrano B. C., Caruntu F. A., Curescu M. G., ...More

PLOS ONE, vol.9, no.7, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 7
  • Publication Date: 2014
  • Doi Number: 10.1371/journal.pone.0101002
  • Journal Name: PLOS ONE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Bursa Uludag University Affiliated: Yes

Abstract

Background: Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-HDV IgM could represent such a marker.